Structural Rationalization of IPMK Inhibitor Potency

Inositol polyphosphate multikinase (IPMK) is a kinase linked to several cancers; recent development of a large panel of ATP-competitive inhibitors has reinvigorated enthusiasm for targeting IPMK. However, the structural basis for how these inhibitors achieve high potency is unknown. Herein, we report 14 novel cocrystal structures (1.7-2.0 resolution) of human IPMK kinase domain with these inhibitors. We also apply a radiolabeled assay and isothermal titration calorimetry that permit high-confidence IC<sub>50</sub> and <i>K</i><sub>D</sub> value determinations. The structures reveal a pocket in the ATP-binding site engaged by the most potent inhibitors. Two ordered waters also participate in hydrogen-bonding networks associated with the most potent inhibitors. In addition to providing the molecular basis for observed increases in potency and selectivity, the data presented here provide a toolbelt of 14 novel inhibitor-bound structures of human IPMK that can serve as a reference for all future IPMK structure-based inhibitor development efforts.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-11-14
DOI
https://doi.org/10.1021/acs.jmedchem.5c02314
Citations
1
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structural Rationalization of IPMK Inhibitor Potency

Stephen B. Shears, Huanchen Wang, Raymond D. Blind
1 citations
Journal of Medicinal Chemistry
Protein Kinase Regulation and GTPase Signaling
0.81
article

Structural Rationalization of IPMK Inhibitor Potency

Stephen B. Shears, Huanchen Wang, Raymond D. Blind
article en
1 citations

Abstract

Inositol polyphosphate multikinase (IPMK) is a kinase linked to several cancers; recent development of a large panel of ATP-competitive inhibitors has reinvigorated enthusiasm for targeting IPMK. However, the structural basis for how these inhibitors achieve high potency is unknown. Herein, we report 14 novel cocrystal structures (1.7-2.0 resolution) of human IPMK kinase domain with these inhibitors. We also apply a radiolabeled assay and isothermal titration calorimetry that permit high-confidence IC<sub>50</sub> and <i>K</i><sub>D</sub> value determinations. The structures reveal a pocket in the ATP-binding site engaged by the most potent inhibitors. Two ordered waters also participate in hydrogen-bonding networks associated with the most potent inhibitors. In addition to providing the molecular basis for observed increases in potency and selectivity, the data presented here provide a toolbelt of 14 novel inhibitor-bound structures of human IPMK that can serve as a reference for all future IPMK structure-based inhibitor development efforts.

Journal of Medicinal ChemistryVol. 68(22)
Vanderbilt University (US), Diabetes Australia (AU), National Institute of Environmental Health Sciences (US), Pharmacology Research Institute (US), Institute of Pharmacology (CZ), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 22%
Protein Kinase Regulation and GTPase Signaling
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.